[11C]MPC6827
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [11C]MPC6827, covering 2025-04-13 to 2025-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Evaluation of [11C]MPC6827 [EARLY_Phase 1]